Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-054064
Filing Date
2012-11-20
Accepted
2012-11-20 16:18:53
Documents
2
Period of Report
2011-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3575
2 POA DOCUMENT poa.txt EX-24.4_445309 3573
  Complete submission text file 0001209191-12-054064.txt   8537
Mailing Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6173416100
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST., ATTN: GENERAL COUNSEL CAMBRIDGE MA 02139
Business Address
Emmens Matthew (Reporting) CIK: 0001298332 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 121218207